Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
18/09/2025
Intel stock price soared 17%.
Latest
3 m ago
Yonghui Supermarket: Appoints Wang Shoucheng as Chief Executive Officer. He served as the head of the adjustment and reform team in the Yonghui Supermarket Donglai Learning Program.
3 m ago
Peak Technology (688279.SH) shareholder Shanghai Huaxin plans to reduce its shareholding by no more than 3%.
4 m ago
Ministry of Finance and other four departments issue a notice on further standardizing issues related to intellectual property asset evaluation.
5 m ago
Pre-market on Thursday, shares of pharmaceutical company Novo Nordisk (NVO) rose by 7.4% after announcing the results of its once-daily weight-loss drug late-stage trial. Novo Nordisk stated that the trial results showed that the drug achieved "significant" weight loss effects comparable to the company's injectable weight-loss drug Wegovy.
5 m ago
Before the opening of the U.S. stock market on Thursday, pharmaceutical company Novo Nordisk saw a 7.4% increase in its stock price after announcing the results of its once-daily weight loss drug late-stage trial. Novo Nordisk stated that the trial results showed that the drug achieved "significant" weight loss effects, comparable to the company's injectable weight loss drug Wegovy.
See all latest